Why the study?
Vascular leak drives organ injury in acute respiratory distress syndrome, and strategies reducing permeability via Angiopoietin-1-Tie2 signaling activation represent promising therapeutic targets.
Does C4BP-ANG1 reduce pathological vascular leakage in preclinical models?
Does C4BP-ANG1 reduce pathological vascular leakage in preclinical models?
A novel recombinant ANGPT1 mimetic, C4BP-ANG1, forms stable heptamers, activates Tie2, and prevents vascular leakage in preclinical models, offering a potential therapy for inflammatory endothelial dysfunction.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for C4BP-ANG1 in vascular leakage; prospective human trials needed before any clinical consideration.
Vascular leak is a key driver of organ injury in diseases such as Acute Respiratory Distress Syndrome caused by viruses, including COVID-19. Strategies that reduce enhanced permeability and vascular inflammation are promising therapeutic targets. Activation of the Angiopoietin-1 (Angpt1)-Tie2 tyrosine kinase signaling pathway is an important regulator of vascular quiescence. Here we describe the design and construction of a new soluble ANGPT1 mimetic that is a potent activator of endothelial Tie2 in vitro and in vivo. Using a chimeric fusion strategy, we replaced the extracellular matrix (ECM) binding and oligomerization domain of ANGPT1 with a heptameric scaffold derived from the C-terminus of serum complement protein C4-binding protein α (C4BP). We refer to this new fusion protein biologic as C4BP-ANG1, which forms a stable heptamer and induces TIE2 phosphorylation in cultured cells, and in the lung following i.v. injection of mice. Injection of C4BP-ANG1 ameliorates VEGF- and lipopolysaccharide-induced vascular leakage, in keeping with the known functions of Angpt1-Tie2 in maintaining quiescent vascular stability, and therefore is a promising candidate treatment for inflammatory endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: